Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors

Eur J Dermatol. 2022 Jul 1;32(4):546-548. doi: 10.1684/ejd.2022.4315.
No abstract available

MeSH terms

  • Alopecia Areata* / chemically induced
  • Alopecia Areata* / drug therapy
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects

Substances

  • Immune Checkpoint Inhibitors

Supplementary concepts

  • Diffuse alopecia